Cannara Biotech (OTC:LOVFF) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cannara Biotech (LOVFF) operate in?

Cannara Biotech is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

Cannara Biotech Stock (OTC: LOVFF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 5.84K
Day Range	- - -
52 Wk Range	0.39 - 0.78
Market Cap	$38.30M
P/E Ratio	9.99
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground

Amid this slowdown, certain products capture consumer interest, even as prices stabilize and competition intensifies.

Nicolás Jose Rodriguez

Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure

Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Tuesday its fiscal third quarter 2024 financial and operating results for the three and nine-month periods ended May 31, 2024. Zohar Krivorot, president and CEO of Cannara, praised the company's "strong performance," during the period, with net revenues reaching CA$19.5 million ($14.2 million) during the quarter, representing a 22.6% year-over-year increase. "Historically, our sales growth has been driven by great customer loyalty and strong demand for our products, amplified by organic word-of-mouth promotion," Krivorot explained. "However, as indicated by our flat quarter-to-quarter results, this can only take us so far. To continue our expansion across the country, we have begun enhancing our sales force and infrastructure."

Jelena Martinovic

Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going

In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024. The report highlights a deceleration in market growth and notable shifts in sales dynamics among leading licensed producers (LPs).

Nicolás Jose Rodriguez

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 5.84K
Day Range	- - -
52 Wk Range	0.39 - 0.78
Market Cap	$38.30M
P/E Ratio	9.99
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cannara Biotech (LOVFF) stock?

You can purchase shares of Cannara Biotech (OTCQB:LOVFF) through any online brokerage.

View our list of the best stock brokerages

Who are Cannara Biotech (LOVFF) competitors?

There are no as such competitors for Cannara Biotech.

What is the forecast, or price target, for Cannara Biotech (LOVFF) stock?

There is no analysis for Cannara Biotech to provide a consensus price target.

What is the current price for Cannara Biotech (LOVFF)?

The stock price for Cannara Biotech (OTCQB: LOVFF) is $0.4255 last updated November 12, 2024 at 10:19 AM EST.

Does Cannara Biotech (LOVFF) pay a dividend?

There are no upcoming dividends for Cannara Biotech.

When is Cannara Biotech (OTCQB:LOVFF) reporting earnings?

Cannara Biotech does not have any upcoming earnings scheduled.

Is Cannara Biotech (LOVFF) going to split?

There is no upcoming split for Cannara Biotech.

What sector and industry does Cannara Biotech (LOVFF) operate in?

Cannara Biotech is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

Comments

Cannara Biotech

Cannara Biotech (LOVFF) Forecast